Dear All,
Further Commentary from DR Niman at Recombinomics on the debate with WHO and CDC (US Centres for Disease Control) regarding the D225G/N Virulence Factor association with fatal cases and the selection of a vaccine strain which may not be protective.
This is a matter of serious concern.
I would put my money on Niman.
This is an important issue in relation to Biota and ensuiring an adequate supply of Relenza
Regards
Kangaroo1
http://www.recombinomics.com/whats_new.html
CDC Comments Raise H1N1 D225G/N Surveillance Concerns
Recombinomics Commentary 15:46
March 8, 2010
CDC In Denial On H1N1 D225G/N Significance
Recombinomics Commentary 23:16
March 7, 2010
CDC Reliance on Negative D225G/N Data Raises H1N1 Concerns
Recombinomics Commentary 19:32
March 7, 2010
CDC On D225G In Egg Isolates Raises H1N1 Vaccine Concerns
Recombinomics Commentary 14:58
March 7, 2010
- Forums
- ASX - By Stock
- BTA
- niman knows more than who
niman knows more than who, page-7
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online